| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214217 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
If equal survival is assumed, SBRT is not cost-effective compared with RFA for inoperable colorectal liver metastases. However, if better local control leads to small survival gains with SBRT, this strategy becomes cost-effective. Ideally, these results should be confirmed with prospective comparative data.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hayeon PhD, Beant MD, Sushil MD, M. Saiful PhD, Mark S. MD, MPP, Kenneth J. MD, MS,